| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $31.7M | +33.2% |
| SG&A Expense | $6.6M | +4.0% |
| Operating Income | -$38.4M | -27.1% |
| Interest Expense | $1.0M | +111.2% |
| Net Income | -$38.8M | -27.0% |
| EPS (Basic) | -$0.65 | -25.0% |
| EPS (Diluted) | -$0.65 | -25.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.6M | -53.1% |
| Current Assets | $20.6M | -50.9% |
| Total Assets | $21.3M | -49.1% |
| Current Liabilities | $13.0M | +44.0% |
| Total Liabilities | $53.5M | +36.4% |
| Stockholders' Equity | -$33.9M | -3898.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$31.1M | -27.8% |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | $10.0M | -72.8% |